Pharma channel feed – Endpoints News

Pharma channel feed

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Past and present FDA adcomm members weigh in on potential reforms

9 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

9 months ago

Federal judge rules against Novartis in Entresto generic lawsuit

9 months ago

IRA price negotiation results to be released Thursday — report

9 months ago

CSL Behring says uptake of hemophilia B gene therapy slower than expected

9 months ago

Galderma wins FDA approval for IL-31 drug in chronic skin disease

9 months ago

Lawmakers renew calls for government to finalize march-in guidance

9 months ago

J&J receives support for $6.5B talc settlement — report

9 months ago

Pressure from anti-China legislation begins to ripple through biopharma

9 months ago

Legend continues Carvykti factory builds to cement CAR-T territory with J&J

9 months ago

Three papers on MDMA are retracted by medical journal, just a day after Lykos' FDA rejection

9 months ago

Ascendis scores FDA approval for hypoparathyroidism candidate to replace Takeda's pulled drug

9 months ago

Pfizer touts strength of RSV vaccine in subgroup of younger immunocompromised patients

9 months ago

Lykos’ MDMA-assisted PTSD treatment rejected by FDA after troubled trial and pushback from experts

9 months ago

Ohio federal judge dismisses IRA suit brought by US Chamber of Commerce

9 months ago

Amgen announces plans for new site in India to strengthen AI, data and life sciences

9 months ago

Hello, neffy: FDA approves first nasal spray for severe allergic reactions

9 months ago

Alfasigma's PBC treatment Ocaliva to face an FDA adcomm in September

9 months ago

23andMe trades drug discovery for GLP-1 weight loss prescriptions

9 months ago

Novavax plots to reduce European footprint to become a ‘leaner’ company

9 months ago

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

9 months ago

Gilead shells out $320M to J&J to buy out rare liver disease drug royalties

9 months ago

Purdue’s emergency opioid overdose treatment is approved by the FDA

9 months ago

First page Previous page 38 39 404142 43 44 Next page Last page